What is Contoura LASIK?

Contoura LASIK is a type of refractive surgery that utilizes WaveLight LASIK technology to create a personalized laser vision correction solution for your eyes. It’s a safe and effective procedure with a long history of successful outcomes. Compared to traditional LASIK and PRK, Contoura LASIK offers a more advanced approach.

Dr. Motwani and Contoura Vision Surgery in San Diego

Dr. Manoj Motwani, a LASIK surgeon in San Diego, specializes in Contoura Vision surgery. This innovative procedure allows us to achieve vision quality potentially exceeding what you were born with, eliminating the need for glasses or contact lenses.

Beyond Glasses and Contacts: The Power of Laser Vision Correction

For centuries, people have relied on glasses and contact lenses to correct vision problems like nearsightedness, farsightedness, and astigmatism. Laser vision correction has emerged as a powerful alternative in the last two decades. At Motwani Lasik Institute, we are particularly skilled in performing Contoura Vision surgery, a procedure that leverages cutting-edge laser technology to deliver exceptional results.

WaveLight Contoura LASIK and the LYRA Protocol: Achieving Superior Vision

For many years, the ultimate goal of laser vision correction has been to create vision “better than normal,” surpassing the limitations of glasses and traditional laser procedures. The LYRA Protocol, developed by Dr. Motwani, it represents a significant step towards this goal – a true revolution in the field.

How Does WaveLight Contoura LASIK Work?

The WaveLight Contoura LASIK system employs the Topolyzer Vario analyzer. This advanced instrument creates a highly detailed map of your cornea, using 22,000 data points to identify any abnormalities or aberrations. The cornea, the clear dome-shaped structure at the front of your eye, plays a crucial role in focusing light. Any irregularities in the cornea can distort light and cause blurry vision.

The detailed information from the Topolyzer is then transmitted to the WaveNet server, which analyzes the cornea and instructs the WaveLight EX500 excimer laser to deliver a customized treatment. Additionally, the system utilizes pupil and iris data to ensure perfect laser alignment during the procedure.

Flap creation is achieved using either the Alcon WaveLight FS200 Femtosecond Laser or the Moria M2 Microkeratome, depending on the doctor’s preference and your specific needs.

The LYRA Protocol: A Powerful Advancement

The Contoura system, when combined with the LYRA Protocol (Layer Yolked Reduction of Astigmatism), represents a breakthrough in laser vision correction. While the FDA approved WaveLight Contoura, surgeons initially lacked a complete understanding of the data this powerful system provided. The FDA studies were conducted with a limited grasp of not only Contoura’s capabilities but also the intricate ways the optical system focuses light on the retina.

Dr. Motwani developed a groundbreaking theory explaining this focusing system and demonstrated its effectiveness through data published in multiple peer-reviewed studies. Additionally, the U.S. Patent Office has granted a patent for this procedure (European patents pending).

The LYRA Protocol delivers tangible results by significantly reducing corneal flaws and distortions. This, in turn, diminishes light scatter, minimizing halos and night glare, potentially reducing the brain’s effort to process and ignore these visual distortions.

Clinical Results: Unprecedented Success Rates

The LYRA Protocol offers a distinct advantage over standard Contoura. Our study involving 50 eyes with significant myopia and astigmatism demonstrated that 80.85% of participants achieved 20/15 vision or better within 3 months post-surgery. Notably, over 60% of patients achieved this exceptional level of vision by the 1-month mark. Results at 6 months, including enhancements, surpass even those initial figures.

The FDA study achieved a success rate of 65% for 20/15 vision, which at the time represented the highest results ever observed in an FDA study for a laser vision correction system. LYRA significantly unlocks the true potential of Contoura, leveraging a new understanding of how the human cornea focuses light for exceptional vision.

Enhanced Visual Quality with Minimal Discomfort

One of the most striking aspects of the LYRA Protocol is the minimal presence of halos and night glare. Many patients report experiencing minimal to no halos around lights at night within days of the procedure. This improvement is attributed to the removal of biological distortions in the cornea, leading to reduced light scatter and glare. Some patients, when asked about halos, haven’t even encountered the phenomenon. Dr. Motwani has published a peer-reviewed paper utilizing a standardized Johns Hopkins survey to analyze subjective results. The findings demonstrated minimal to no visual complaints across the entire spectrum of the qualitative survey, surpassing expectations.